373 related articles for article (PubMed ID: 23472056)
1. Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.
Carrara VI; Lwin KM; Phyo AP; Ashley E; Wiladphaingern J; Sriprawat K; Rijken M; Boel M; McGready R; Proux S; Chu C; Singhasivanon P; White N; Nosten F
PLoS Med; 2013; 10(3):e1001398. PubMed ID: 23472056
[TBL] [Abstract][Full Text] [Related]
2. Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity.
Na-Bangchang K; Muhamad P; Ruaengweerayut R; Chaijaroenkul W; Karbwang J
Malar J; 2013 Jul; 12():263. PubMed ID: 23898808
[TBL] [Abstract][Full Text] [Related]
3. Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative.
Carrara VI; Sirilak S; Thonglairuam J; Rojanawatsirivet C; Proux S; Gilbos V; Brockman A; Ashley EA; McGready R; Krudsood S; Leemingsawat S; Looareesuwan S; Singhasivanon P; White N; Nosten F
PLoS Med; 2006 Jun; 3(6):e183. PubMed ID: 16719547
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Saito M; Carrara VI; Gilder ME; Min AM; Tun NW; Pimanpanarak M; Viladpai-Nguen J; Paw MK; Haohankhunnatham W; Konghahong K; Phyo AP; Chu C; Turner C; Lee SJ; Duanguppama J; Imwong M; Bancone G; Proux S; Singhasivanon P; White NJ; Nosten F; McGready R
BMC Med; 2021 Jun; 19(1):132. PubMed ID: 34107963
[TBL] [Abstract][Full Text] [Related]
5. Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors.
Phyo AP; Ashley EA; Anderson TJC; Bozdech Z; Carrara VI; Sriprawat K; Nair S; White MM; Dziekan J; Ling C; Proux S; Konghahong K; Jeeyapant A; Woodrow CJ; Imwong M; McGready R; Lwin KM; Day NPJ; White NJ; Nosten F
Clin Infect Dis; 2016 Sep; 63(6):784-791. PubMed ID: 27313266
[TBL] [Abstract][Full Text] [Related]
6. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
Muhamad P; Thiengsusuk A; Phompradit P; Na-Bangchang K
Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919
[TBL] [Abstract][Full Text] [Related]
7. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.
Nosten F; van Vugt M; Price R; Luxemburger C; Thway KL; Brockman A; McGready R; ter Kuile F; Looareesuwan S; White NJ
Lancet; 2000 Jul; 356(9226):297-302. PubMed ID: 11071185
[TBL] [Abstract][Full Text] [Related]
8. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.
Na-Bangchang K; Ruengweerayut R; Mahamad P; Ruengweerayut K; Chaijaroenkul W
Malar J; 2010 Oct; 9():273. PubMed ID: 20929590
[TBL] [Abstract][Full Text] [Related]
9. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
Satimai W; Sudathip P; Vijaykadga S; Khamsiriwatchara A; Sawang S; Potithavoranan T; Sangvichean A; Delacollette C; Singhasivanon P; Kaewkungwal J; Lawpoolsri S
Malar J; 2012 Aug; 11():300. PubMed ID: 22929621
[TBL] [Abstract][Full Text] [Related]
10. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment.
Carrara VI; Zwang J; Ashley EA; Price RN; Stepniewska K; Barends M; Brockman A; Anderson T; McGready R; Phaiphun L; Proux S; van Vugt M; Hutagalung R; Lwin KM; Phyo AP; Preechapornkul P; Imwong M; Pukrittayakamee S; Singhasivanon P; White NJ; Nosten F
PLoS One; 2009; 4(2):e4551. PubMed ID: 19234601
[TBL] [Abstract][Full Text] [Related]
11. Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders.
Wongsrichanalai C; Sirichaisinthop J; Karwacki JJ; Congpuong K; Miller RS; Pang L; Thimasarn K
Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):41-9. PubMed ID: 11485094
[TBL] [Abstract][Full Text] [Related]
12. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
Lim P; Alker AP; Khim N; Shah NK; Incardona S; Doung S; Yi P; Bouth DM; Bouchier C; Puijalon OM; Meshnick SR; Wongsrichanalai C; Fandeur T; Le Bras J; Ringwald P; Ariey F
Malar J; 2009 Jan; 8():11. PubMed ID: 19138391
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
[TBL] [Abstract][Full Text] [Related]
14. Declining mefloquine sensitivity of Plasmodium falciparum along the Thai-Myanmar border.
Rojanawatsirivet C; Congpuong K; Vijaykadga S; Thongphua S; Thongsri K; Bangchang KN; Wilairatana P; Wernsdorfer WH
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):560-5. PubMed ID: 15689066
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003.
Suwandittakul N; Chaijaroenkul W; Harnyuttanakorn P; Mungthin M; Na Bangchang K
Korean J Parasitol; 2009 Jun; 47(2):139-44. PubMed ID: 19488420
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.
Lee SJ; Ter Kuile FO; Price RN; Luxemburger C; Nosten F
PLoS One; 2017; 12(2):e0168780. PubMed ID: 28192434
[TBL] [Abstract][Full Text] [Related]
17. Molecular surveillance of artemisinin resistance falciparum malaria among migrant goldmine workers in Myanmar.
Nyunt MH; Wang B; Aye KM; Aye KH; Han JH; Lee SK; Han KT; Htut Y; Han ET
Malar J; 2017 Mar; 16(1):97. PubMed ID: 28249583
[TBL] [Abstract][Full Text] [Related]
18. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
[TBL] [Abstract][Full Text] [Related]
19. Novel Cross-Border Approaches to Optimise Identification of Asymptomatic and Artemisinin-Resistant Plasmodium Infection in Mobile Populations Crossing Cambodian Borders.
Edwards HM; Canavati SE; Rang C; Ly P; Sovannaroth S; Canier L; Khim N; Menard D; Ashton RA; Meek SR; Roca-Feltrer A
PLoS One; 2015; 10(9):e0124300. PubMed ID: 26352262
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar border.
Hoglund RM; Ruengweerayut R; Na-Bangchang K
Malar J; 2018 Sep; 17(1):322. PubMed ID: 30176888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
